Probably, the side effect of a medicine -- taken without any prescription or after consultation with doctor -- incapacitated the pilot, according to an investigation report into an incident involving a SpiceJet flight three years ago.
The incident pertains to a SpiceJet flight from Mumbai to Hyderabad that was carrying 150 people, including six crew members.
At the time of landing in Hyderabad, a medical emergency was declared due to incapacitation of the pilot-in-command. The flight landed safely and there was no injury to the people on board or damage to the aircraft.
AAIB, which mainly probes serious incidents involving aircraft in the Indian airspace, has also made certain safety recommendations to aviation regulator DGCA.
"The most probable cause of the PIC (pilot-in-command) getting incapacitated was due to side-effect of a pain killer which was taken by the PIC without any prescription or consultation by a doctor," the report, which has just been made public by the DGCA, said.
The investigation report, dated February 1, 2017, has been made public. The incident happened on January 8, 2014.
During the flight, the pilot experienced pain in the neck and consumed a pain killer medicine in flight to subside the pain, the report said.
While the flight was on descent, the pilot "experienced partial loss of hearing and a blurred vision and decided to take an anti-allergic tablet to counter the presumed reaction of the pain killer medicine", it added.
AAIB has recommended that the DGCA should "sensitise all the scheduled operators and non-scheduled operators with a circular directing all operators to educate their flight crew and cabin crew of the consequences of self-medication and also the importance of communicating any ailments to the company doctor during the pre-flight medical".
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
